Antidiabetic Activity of the Methanol Fraction of Sungkai Leaves (Peronema canescens Jack)
DOI:
https://doi.org/10.21776/ub.jpacr.2023.012.02.699Keywords:
Diabetes Melitus, Antidiabetic, Sungkai Leaves, FlavonoidAbstract
Diabetes Mellitus (DM) is one of a group of metabolic diseases characterized by hyperglycemia caused by a disturbance in insulin so that blood glucose levels increase. Prevention of absorption of blood glucose by the intestine can be done with the help of the enzyme α-glucosidase. Based on the results of phytochemical tests, it is known that the methanol fraction of sungkai leaves contains flavonoid compounds. The Fourier Transform Infra-Red (FTIR) spectrum showed that the isolates had phenolic O-H groups (3,354.53 cm-1, 1,359.28 cm-1), aromatic C=C group (1,615.48 cm-1), C-O-C ether group (1,046.60 cm-1) and aromatic C-H group (822.21 cm-1). In vivo antidiabetic activity test was carried out using test animals of white male mice which were induced by alloxan. Antidiabetic testing was carried out using 6 treatment groups with glibenclamide, Na-Carboxymethyl cellulose (Na-CMC) 0.5%, dose 175 mg/kgBW, 350 mg/kgBW, 700 mg/kg Body Weight (BW) and isolates 2 mg/kgBW. The results showed that the methanol fraction of sungkai leaves had the best antidiabetic activity at a dose of isolate and 700 mg/kgBW which was able to reduce blood glucose levels by 42.20% and 42.00%. In vitro antidiabetic testing through α-glucosidase enzyme inhibition mechanism did not show any antidiabetic activity at concentrations of fractions 5, 10, 25, 50 and 100 ppm.
Downloads
References
[1] Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K.B., Ostolaza, H. and MartÃn, C., Int. J. Mol. Sci., 2020, 21(17), p.6275.
[2] Craig, M.E., Hattersley, A. and Donaghue, K.C., Pediatr Diabetes, 2009, 10(Suppl 12), pp.3-12.
[3] Arifin, H., Chou, K.R., Ibrahim, K., Fitri, S.U.R.A., Pradipta, R.O., Rias, Y.A., Sitorus, N., Wiratama, B.S., Setiawan, A., Setyowati, S. and Kuswanto, H., J. Multidiscip. Healthc., 2022, pp.2203-2221.
[4] Banday, M.Z., Sameer, A.S. and Nissar, S., Avicenna J. Med., 2020, 10(04), pp.174-188.
[5] S. Sinulingga, S., Subandrate, S. and Safyudin, S., Jurnal Kedokteran dan Kesehatan, 2020, 16(1), pp.76-83.
[6] Sari, S.G., Rahmawati, R., Rusmiati, R. and Susi, S., EnviroScienteae, 2023, 19(1), pp.35-40.
[7] Kusriani, R.H., Nawawi, A. and Turahman, T., Jurnal Farmasi Galenika, 2015, 2(1), pp.8-14.
[8] Andriani, F., Sundaryono, A. and Nurhamidah, N., Alotrop, 2017, 1(1), 33-38.
[9] Latief, M., Lizawati, L., Tarigan, I.L., Muhaimin, M. and Sari, P.M., AIP Conference Proceedings, 2023, 2595, 080004.
[10] Ahmad, I. and Ibrahim, A., Jurnal Sains dan Kesehatan, 2015, 1(3), pp.114-119.
[11] Prasiwi, D., Sundaryono, A. and Handayani, D., Alotrop, 2018, 2(1), 25-32.
[12] Fikriansyah, M., Latief, M. and Tarigan, I.L., CHEMPUBLISH JOURNAL, 2023, 7(1), pp.54-63.
[13] N. A. P. Pakpahan, “Isolasi dan Uji Aktivitas Antikolesterol Senyawa Metabolit Sekunder dari Fraksi n-Heksana Daun Sungkai (Peronema canescens Jack),†Bachelor Thesis, Sriwijaya University, Palembang, 2021.
[14] Tarigan, I.L., Aini, I.P.S. and Latief, M., Pharmacogn. J., 2022, 14(6), 744-752.
[15] Br, Sitepu N., Asian J.Pharm. Res. Dev., 2020, 8(3), pp.59-61.
[16] Z. A. Amani & R. Mustarichie, Farmaka, 2018, 16 (1), 127–132.
[17] Dillasamola, D., Aldi, Y., Wahyuni, F.S., Rita, R.S., Umar, S. and Rivai, H., Pharmacogn. J., 2021, 13(6), 1397-1407.
[18] Nuraskin, C.A., Idroes, R. and Soraya, C., Res. J. Pharm. Technol., 2019, 12(11), pp.5247-5250.
[19] Khalivulla, S.I., Mohammed, A. and Mallikarjuna, K., Curr. Pharm. Des., 2021, 27(6), pp.775-788.
[20] Kokalj Ladan, M., Straus, J., TavÄar Benković, E. and Kreft, S., Sci. Rep., 2017, 7(1), p.7226.
[21] Mahmiah, M., Indones. J. Chem., 2006, 6(3), pp.312-315.
[22] Al-Ishaq, R.K., Abotaleb, M., Kubatka, P., Kajo, K. and Büsselberg, D., Biomolecules, 2019, 9(9), p.430.
[23] Li, C.X., Li, T.H., Zhu, M., Lai, J. and Wu, Z.P., J. Funct. Foods., 2021, 85, p.104638.
[24] Kottaisamy, C.P.D., Raj, D.S., Prasanth Kumar, V. and Sankaran, U., Lab. Anim. Res., 2021, 37(1), pp.1-14.
[25] Zhang, M., Montroy, J., Sharma, R., Fergusson, D.A., Mendelson, A.A., Macala, K.F., Bourque, S.L., Schlechte, J.M., Eng, M.K., McDonald, B. and Gill, S.E., Crit. Care Explor., 2021, 3(6), p.e0433.
[26] Soares, J.M.D., Leal, A.E.B.P., Silva, J.C., Almeida, J.R. and de Oliveira, H.P., Pharmacogn. Mag., 2017, 13(52), p.639.
[27] Garcia-Molina, P., Garcia-Molina, F., Teruel-Puche, J.A., Rodriguez-Lopez, J.N., Garcia-Canovas, F. and Muñoz-Muñoz, J.L., Molecules, 2022, 27(10), p.3141.
[28] U. Hossain, A. K. Das, S. Ghosh, & P. C. Sil, Food Chem. Toxicol., 2020, 145, 111738.
[29] Rehani, P.R., Iftikhar, H., Nakajima, M., Tanaka, T., Jabbar, Z. and Rehani, R.N., J. Diabetes Res., 2019, 4267357.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).